Semicarbazone – a versatile therapeutic pharmacophore for fragment based anticonvulsant drug design
Open Access
|Nov 2012References
- 1. M. Meonardi and T. Ustun, The global burden of epilepsy,(2002) 21_25; DOI: 10. 1046/j.1528-1157.43.s.6.11.x.
- 2. R. Sridharan and B. N. Murthy, Relevance and pattern of epilepsy in India,(1999) 631_636; DOI: 10.1111/j.1528-1157.1999.tb05566x.
- 3. G. F. Carl and M. L. Smith, Phenytoin-folate interaction differing effect of the sodium salt and the free acid of phenytoin,(1992) 372_375; DOI: 10.1111/j.1528-1157.1992tb02330x.
- 4. P. Kwan and M. J. Brodie, Phenobarbital for the treatment of epilepsy in the 21st century, a critical review,(2004) 1141_1149; DOI: 10.1111/j.0013-9580.2004.12704.x.
- 5. S. D. Shorvon, Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959_2009,(suppl. 3) (2009) 93_130; DOI: 10.1111/j.1528-1167.2009.02042.x.
- 6. A. C. Foster and J. A. Kemp, Glutamate and GABA-based CNS therapeutics,(2006) 7_17.
- 7. M. Mazza, G. Della Marcla and M. DiNicola, Oxacarbazepine improves mood in the patients with epilepsy,(2007) 397_401; DOI: 10.1016/j.yebeh.2007.01.003.
- 8. J. M. Rho, S. D. Donevan and M. A. Rogawaski, Barbiturate like action of the propanediol dicarbamate felbamate and meprobamate,(1997) 1383_1391.
- 9. C. Salome, E. Salome-Grosjean, J. P. Stables and H. Kohn, Merging the structural motifs of functionalized amino acids and alpha amino amides: compounds with significant anticonvulsant activities,(2010) 3756_3771; DOI: 10.1021/jm 100185c.
- 10. A. C. Errington, L. Coyne, T. Stohr, N. Selve and G. Lees, Seeking a mechanism of action for the novel anticonvulsant lacosamide,(2006) 1016_1024; DOI: 10.1016/j.neuropharm. 2006.02002.
- 11. R. G. Fariello, Safinamide,(2007) 110_116; DOI: 10.1016/j.nurt.2006.11.011.
- 12. N. D. Eddington, D. S. Cox, R. R. Roberts, J. P. Stables, C. B. Powells and K. R. Scott, Enaminonesversatile therapeutic pharmacophores, Further advances,(2000) 417_436.
- 13. S. N. Pandeya and J. R. Dimmock, Recent evaluation of thiosemicarbazones and semicarbazones and related compounds for antineoplastic and anticonvulsant activities,(1993) 659_666.
- 14. H. Beraldo and D. Gambino, The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes,(2004) 31_39.
- 15. L. Liu, T. Zeng, M. J. Morris, C. Wallengren, A. L. Clarke, C. A. Reid, S. Petrou and T. J. O’Brien, The mechanism of carbamazepine aggravated of absence seizures,(2006) 790_798; DOI: 10.1124/jpet.106.10496.
- 16. S. N. Ghalmi, D. A. Berv, J. Klugman, K. J. Rosenquist and D. J. Hsu, Oxacarbazepine. Treatment of bipolar disorder,(2003) 943_945; DOI: 10.4088/JCP.v64n0813.
- 17. C. Dulsat, N. Mealy, R. Castaner and J. Bolos, Eslicarbazepine acetate. Drugs Fut.(2009) 189_199; DOI: 10.1358/dof.2009.034.03.1352675.
- 18. D. Schmidt and K. Utech, Progabide for refractory partial epilepsy: A controlled add-on trial,(1986) 217_221.
- 19. S. C. Vashishtha, G. A. Zello, K. H. Nienaber, J. Balzarini, E. D. Clercq, J. P. Stables and J. R. Dimmock, Cytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compounds,(2004) 27_35.
- 20. S. K. Sridhar, S. N. Pandeya, J. P. Stables and A. Ramesh, Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives,(2002) 129_132.
- 21. F. D. Popp, Potential anticonvulsants, VII Some hydrazones of indole-3-carboxaldehyde,(1984) 617_619.
- 22. J. Jain, Y. Kumar, R. Sinha, R. Kumar and J. Stables, Menthone aryl acid hydrazones: A new class of anticonvulsants,(2011) 56_61.
- 23. J. O. McNamara,in(Ed. J. G. Hardman, L. E. Limbird, P. B. Molinoaff and R. W. Ruddon), 9th ed., McGraw Hill, New York 2001, pp. 461_486.
- 24. S. Coker, The use of phenacemide for intractable partial complex epilepsy in children,(1986) 230_232; DOI: 10.1016/0887-8994(86)90053-6.
- 25. T. R. Browne, „Fosphenytoin (cerebyx),(1997) 1_12; DOI: 10.1097/00002826-199702000-00001.
- 26. P. N. Patsalos, Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies,(S9) (2005) 140_144; DOI: 10.1111/j.1528-1167.2005.00326.x.
- 27. R. Kaliviainen, K. Eriksson and I. Parviainan, Refractory generalized convulsive status epileptics: a guide to treatment,(2005) 759_768; DOI: 10.2165/00023210-200519090-00003.
- 28. J. R. Dimmock, R. N. Pathucode, J. Tuchck and G. B. Baker, Anticonvulsant activities of 4(4’-fluorophenyl) benzaldehyde semicarbazones,(1999) 112_125.
- 29. Y. Wang, S. X. Cai and J. F. W. Keanaan, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 638, 947, 28 Oct 2003.
- 30. J. R. Dimmock, Semicarbazones having CNS activity and pharmaceutical preparations containing same, U.S. Pat. 5, 741, 818, 21 Apr. 1998.
- 31. Y. Wang, S. X. Cai, N. C. Lam, J. F. W. Keanan, VI Ilynin and E Weber, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 613, 803, 2 Sept 2003.
- 32. S. X. Cai, N. C. Lam and S. Hongbal, Substituted semicarbazides and the use thereof, U. S. Pat. 6, 281, 211, 28 Aug 2001.
- 33. S. N. Pandeya, V. Mishra, P. N. Singh and D. C. Rupainwar, Anticonvulsant activity of thiouriedo derivatives of acetophenone semicarbazone,(1998) 17_22.
- 34. V. I. Ilynin, J. D. Ponionis, G. T. Whiteside, J. E. Harrison, M. S. Meason, L. Mork, P. E. Turdin, S. Cooh, R. B. Caster, P. Nguyen, D. S. Hogencamp, S. Olanreqwajn, E. Benzamin and R. N. Woodward, Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy) phenyl]-pyrimidine-4-carboxamide (PPPA): A Potent, broad spectrum state dependent sodium channel blocker for treating painstates,(2006) 1086_1093.
- 35. J. R. Dimmock, R. N. Puthucode, M. S. Lo, J. W. Quail, J. Yang and J. P. Stables, Structural modification of the primary amino group of anticonvulsant aryl semicarbazones,(1996) 83_88.
- 36. S. N. Pandeya, N. Aggarwal and J. S. Jain, Evaluation of semicarbazones for anticonvulsant and sedative hypnotic properties,(1999) 300_312.
- 37. S. N. Pandeya, V. Mishra, I. Ponnilavarsan and J. P. Stables, Anticonvulsant activity ofchlorophenyl substituted arylsemicarbazones - the role of primary terminal amino group,(2000) 283_290.
- 38. S. N. Pandeya, P. Yogeeswari and J. P. Stables, Synthesis and anticonvulsant activity of 4-bromophenyl substituted arylsemicarbazones,.(2000) 879_886.
- 39. P. Yogeeswari, J. V. Raghvendran, R. Thirumurugan, S. Induja, D. Sriram and J. P. Stables, Synthesis and structure activity relationship on anticonvulsant arylsemicarbazones,(2006) 55_62.
- 40. J. Jain, Y. Kumar, J. P. Stables and R. Sinha, Menthone semicarbazides and thiosemicarbazides as anticonvulsant agents,(2010) 44_50.
- 41. K. Verma, S. N. Pandeya, V. K. Singh, S. Gupta, P. Prashant, Anurag and G. Bhardwaj, Synthesis and pharmacolgical activity of some substituted menthone semicarbazones and thiosemicarbazone derivatives,(2009) 357_362.
- 42. H. P. Singh, C. S. Chauhan, S. N. Pandeya and C. S. Sharma, Chalcone semicarbazone: a new scaffold for antiepileptic drug discovery,(2010) 103_106; DOI: 10.4067/50717-970720 10000 100024.
- 43. H. P. Singh, S. N. Pandeya, C. S. Chauhan and C. S. Sharma, Synthesis and pharmacological screening of some novel chalconyl derivatives of substituted phenylsemicarbazide,; DOI: 1007/S00044-000-9277-6.
- 44. H. P. Singh, C. S. Chauhan, S. N. Pandeya, C. S. Sharma, B. Srivastava and M. Singhal, Synthesis and pharmacological screening of some novel chloro chalcone semicarbazone derivatives,(2010) 343_357.
- 45. S. N. Pandeya, A. K. Agrawal, A. Singh and J. P. Stables, Design and synthesis of semicarbazones and their sioisosteric analogues as potent anticonvulsant: The role of hydrogen bonding,(2003) 15_24.
- 46. P. Yogeeswari, D. Sriram, S. N. Pandeya and J. P. Stables, 4-Sulphamoyl semicarbazones with anticonvulsant activity,(2004) 609_613; DOI: 10.1016/j.farmac.2004.01.009.
- 47. R. Thirumurugan, D. Sriram, A. Saxena, J. P. Stables and P. Yogeeswari, 2,4-Dimethoxy phenylsemicarbazones with anticonvulsant activity against three animal models of seizures. Synthesis and pharmacological evaluation,(2006) 3106_3112.
- 48. P. Yogeeswari, R. Thirumurugan, R. Kavya, J. S. Samuel and J. P. Stables, 3-Chloro-2-methyl phenyl substituted semicarbazones: Synthesis and anticonvulsant activity,.(2004) 729_734.
- 49. P. Yogeeswari, D. Sriram, V. Veena, R. Kavya, R. Rakhra, J. V. Raghvendran, S. Mehta, R. Thirumurugan and J. P. Stables, Synthesis of arylsemicarbazones as potential anticonvulsants agents,(2005) 57_55; DOI: 10.1016/j.biopha 2004.04.013.
- 50. S. N. Pandeya, I. Ponnilavarasan, A. Pandey, R. Lakhan and J. P. Stables, Evaluation ofnitrophenyl substituted semicarbazones for anticonvulsant properties,(1999) 923_925.
- 51. N. Aggarwal, P. Mishra, B. P. Nagori, R. Aggrawal and J. Jain, Anticonvulsant and neurotoxicity evaluation of some(4)-phenylsubstituted pyridyl semicarbazones,(2009) 245_249; DOI: 10.1016/j.ejps 2003.08.002.
- 52. A. S. Raja, S. N. Pandeya, S. S. Panda and J. P. Stables, Synthesis and anticonvulsant evaluation of semicarbazones of acetophenone Mannich bases,(2007) 302_307.
- 53. S. Mehta, P. Yogeeswari, D. Sriram and S. Induja, Microwave-assisted synthesis, anticonvulsant activity and quantum mechanical modeling of-(4-bromo-3-methyl phenyl) semicarbazones,,(2007) 45_55; DOI: 10.1631/ZUS 2007.B0045.
- 54. S. Mehta, P. Yogeeswari, D. Sriram, P. Kendyer, P. R. Kumar, S. Induja and J. P. Stables, Quantum mechanical modelling of4-(2,5-disubstituted phenyl) semicarbazones: Synthesis and anticonvulsant activity of4-(2,5-dimethyl phyenyl/2-fluoro-5-methyl phenyl) semicarbazones,(2006) 617_625.
- 55. P. Yogeeswari, D. Sriram, R. Thirumurugan, J. V. Ragvendran, K. Sudhansu and J. P. Stables, Discovery of-[2,6-dimethylphenyl) substituted semicarbazones as anticonvulsant effective against various animal model of seizures with GABA-T-inhibitory activity,(2005) 6202_6211; DOI: 10.1021/jm050283b.
- 56. F. Azam, T. A. Alkaskas, S. L. Khokra and O. Prakash, Synthesis of novel1-(naphtha[1,2-d] thiazol-2-yl) semicarbazides as potential anticonvulsant,.(2009) 203_211.
- 57. N. Siddiqui, A. Rana, S. A. Khan, M. A. Bhat and S. E. Haque, Synthesis of benzthiazole semicarbazones as novel anticonvulsant. The role of hydrophobic domain,(2007) 4178_4182; DOI: 10.1002/ardp.200800130.
- 58. S. Mehta, R. K. Pavana, P. Yogeeswari, D. Sriram, J. P. Stables, Heteroaryl-substituted semicarbazones. Synthesis and anticonvulsant activity of-(3-methyl pyridine-2-yl)-substituted semicarbazones,(2009) 1287_1293; DOI: 10.1002/jRet 5570430522.
- 59. N. Aggarwal and P. Mishra, Synthesis and evaluation of 4-substituted Semicarbazones of levulinic acid for anticonvulsant activity,(2005) 617_621; DOI: 10.1631/jZUS.2005.B0617.
- 60. M. Taroua, C. Ribuot, M. H. Pera, G. Tailandier, M. Fatome, J. D. Laval, P. Demengec and G. Leclerc, New _-, _- and _-semicarbazone and thiosemicarbazone 1,3-dithiolones as radioprotectors anticonvulsant activity,.(1996) 589_595; DOI: 10.1002chin.1996 461 40.
- 61. H. Rajak, R. Deshmukh, N. Aggarwal, S. Kashaw, M. D. Kharya and P. Mishra, Synthesis of novel 2,5-disubstituted-1,3,4-thiadiazoles for their potential anticonvulsant activity: Pharmacophoric model studies,(Weinheim)(2009) 453_461.
- 62. N. Siddiqui, M. F. Arshad and S. A. Khan, Synthesis of some new coumarin incorporated thiazoylsemicarbazones as anticonvulsants,(2009) 161_167.
- 63. I. Ponnilavarasan, S. Ganguly and V. Pandit, Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsants and antimicrobial agents,(2010) 703_706.
- 64. J. R. Dimmock and G. B. Baker, Anticonvulsant activities of 4-bromobenzaldehyde semicarbazones,(1994) 648_655; DOI: 10.1111/j.1528-1157.1994.tb02486x.
- 65. S. N. Pandeya, H. Manjula and J. P. Stables, Design of semicarbazones and their bio-isosteric analogues as potential anticonvulsants,(2001) 121_124.
- 66. S. N. Pandeya, B. N. Singh and J. Mishra, Synthesis and biological activity of substituted arylsemicarbazones,(2007) 85_92.
- 67. S. N. Pandeya, S. Smitha and J. P. Stables, Anticonvulsant and sedative-hypnotic activities of-substituted isatin semicarbazones,(Weinheim)(2002) 129_134; DOI: 10.1002/1521-4184(200204).
- 68. S. N. Pandeya, S. Kohli, N. Siddiqui and J. P. Stables, Synthesis and anticonvulsant activities of 4--substituted arylsemicarbazones,(2003) 565_571.
- 69. S. N. Pandeya, A. S. Raja and J. P. Stables, Synthesis of isatin semicarbazones as novel anticonvulsant role of hydrogen bonding,(2002) 266_271.
- 70. A. Singh, C. Pande, P. Gahtori, S. N. Pandeya and J. P. Stables, Design and synthesis of some novel 4(4-substituted aryl) semicarbazones as anticonvulsant agents,(2010) 363_367; DOI: 10.4103 10250-474x70485.
- 71. N. Aggarwal and P. Mishra, Synthesis of 4-arylsubstituted semicarbazones of some terpenes as novel anticonvulsants,(2004) 260_264.
- 72. N. Aggrawal, R. Aggarwal, P. Mishra, J. S. Jain, S. K. Bansal and K. K. Jha, Design and evaluation of semicarbazones and thiosemicarbazones as novel anticonvulsants,(2008) 26_28.
- 73. J. R. Dimmock, K. K. Sidhu, R. S. Thayer, P. Mack, M. J. Duffy, R. S. Reid, J. W. Quail, U. Pugazhenthi, A. Ong, J. A. Bikker and D. F. Weaver, Anticonvulsant activities of some arylsemicarbazones, displaying potent oral activity in the maximal electroshock screen in rats acconpanied by high protective indices,(1993) 2243_2265; DOI: 10.1021/jm000689001.
- 74. J. R. Dimmock, K. K. Sidhu, S. D. Thumber, S. D. Basram, M. Chen, J. W. Quail, J. Yang, I. Rozas and D. F. Weaver, Some arylsemicarbazones possessing anticonvulsant activity,(1995) 287_301.
- 75. J. R. Dimmock, R. N. Puthucode, J. M. Smith, M. Hetherington, J. W. Quail, U. Pugazhenthi, R. Lecher and J. P. Stables, (Aryloxy) aryl semicarbazones and related compounds: A novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen,(1996) 3984_3997; DOI: 10.1021/jm9603025.
- 76. R. N. Puthucode, U. Pugazenthi, J. W. Quail, J. P. Stables and J. R. Dimmock, Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones,(1998) 595_607.
- 77. J. R. Dimmock, H. A. Semple, S. John, M. A. Beazely and G. D. Abrams, Isolation and identification of the major urinary metabolite of 4-(4-fluorophenoxy)benzaldehyde semicarbazones after oral dosing to rats,(1999) 260_262.
- 78. K. Ramu, G. N. Lam and H. Huges, In vivo metabolism and mass balance of 4[4-fluorophenylbenzaldehyde semicarbazone (CO102862) in rats,(2000) 1153_1161.
- 79. K. Ramu, G. N. Lam and B. Chin, Development of a high-performance liquid chromatorgraphy tandem mass spectrum of the method for the determination of pharmacokinetic of C0102802 in mouse, rat, monkey and dogs plasma,(2000) 1_15.
- 80. N. C. Lam, Sodium channel blocker compositions and the use thereof, Pat. W0 00/6 11 88, 19 Oct. 2000.
- 81. N. Micale, M. Zappala, S. Grazzo, G. Puja, G. Desarro, G. Ferreri, A. Desarro, L. Toma and C. Di Michali, Novel potent AMP/Kainate receptor antagonists : Synthesis and anticonvulsant activity of series of 2[(4-alkyl semicarbazono)-(4-aminophenyl) methyl)-4,5-methylene dioxy phenylacetic acid alkyl esters,(2002) 4433_4442.
- 82. N. Siddiqui, M. S. Alam and W. Ahsan, Synthesis, Anticonvulsant and toxicity evaluation of 2(1-indol-3yl)acetyl--substituted phenyl) hydrazine carbothioamides and their related heterocyclic derivatives,(2008) 445_459; DOI: 10.2478/v1007-008-0025-0.5.
- 83. S. Mehta, P. Yogeeswari, D. Sriram and J. P. Stables, Cyclization of the semicarbzone template of arylsemicarbazones: Synthesis and anticonvulsant activity of 4,5-(diphenyl)-2H-1,2,4-triazole-3-(4H)-one,(2009) 187_193; DOI: 10.1016/j.biopha.2006.04.002.
- 84. P. Czapinski, B. Blaszezyk and S. J. Czuczwar, Mechanism of action of antiepileptic drugs,(2005) 3_14.
- 85. V. I. Ilyin, D. D. Hodges, E. R. Whitmore, R. B. Carter, S. X. Cai and R. M. Woodward, V102862 (CO102862): A potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels,(2005) 801_812; DOI: 10.1038/sj.bjp.0706058.
- 86. P. Yogeeswari, D. Sriram, A. Brahmanandan, I. Sridharan, R. Thirumurugan and J. P. Stables, Synthesis of novel arylsemicarbazones as anticonvulsants with GABA-mediated mechanism,(2003) 57_68.
- 87. W. E. Stone and M. J. Javid, Quantititative evaluation of the action of anticonvulsants against different chemical convulsants,(1979) 66_78.
- 88. W. E. Stone and M. J. Javid, Anticonvulsant and convulsive effects of lidocaine: Comparison with those of phenytoin, and implication for mechanism of action concepts,(1988) 161_168.
- 89. R. L. McDonald and K. M. Kelly, Antiepileptic drug mechanism of action,(Suppl. 2S) (1995) 2_12.
- 90. P. Yogeeswari, J. V. Ragavendran, D. Sriram, V. Nageswari, R. Kavya, N. Srivastsan, K. Vanitha and J. P. Stables, Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach,(2007) 2459_2467; DOI: 10.1021/jm061431g.
- 91. B. Malawaska and A. Scatturin, Application of pharmacophore models for the design and synthesis of new anticonvulsant drugs,(2003) 341_348.
- 92. J. Riss, J. Cloyd, J. Gates and S. Collins, Benzodiazepines in epilepsy pharmacology and pharmacokinetics,(2008) 64_86; DOI: 10.1111/j.1600-0404.2008.01004.x.
Language: English, Croatian, Slovenian
Page range: 263 - 286
Published on: Nov 6, 2012
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2012 Surendra Nath Pandeya, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.